$966 Million is the total value of Soleus Capital Management, L.P.'s 77 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | PEPGEN INC | $0 | – | -10,000 | -100.0% | -0.02% | – | |
| KIDS | Exit | ORTHOPEDIATRICS CORP | $0 | – | -7,471 | -100.0% | -0.04% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -14,727 | -100.0% | -0.06% | – |
| CUTR | Exit | CUTERA INC | $0 | – | -20,000 | -100.0% | -0.13% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AGnamen akt | $0 | – | -22,000 | -100.0% | -0.13% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -38,000 | -100.0% | -0.22% | – |
| KDNY | Exit | CHINOOK THERAPEUTICS INC | $0 | – | -78,000 | -100.0% | -0.29% | – |
| PEN | Exit | PENUMBRA INC | $0 | – | -9,300 | -100.0% | -0.30% | – |
| NEOG | Exit | NEOGEN CORP | $0 | – | -143,500 | -100.0% | -0.31% | – |
| Exit | VENTYX BIOSCIENCES INC | $0 | – | -69,000 | -100.0% | -0.32% | – | |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -9,600 | -100.0% | -0.36% | – |
| TXG | Exit | 10X GENOMICS INC | $0 | – | -70,000 | -100.0% | -0.37% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -236,000 | -100.0% | -0.37% | – |
| ESTA | Exit | ESTABLISHMENT LABS HLDGS INC | $0 | – | -39,920 | -100.0% | -0.38% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -31,100 | -100.0% | -0.49% | – |
| BLI | Exit | BERKELEY LTS INC | $0 | – | -1,330,000 | -100.0% | -0.51% | – |
| Exit | IMAGO BIOSCIENCES INC | $0 | – | -115,000 | -100.0% | -0.59% | – | |
| DXCM | Exit | DEXCOM INC | $0 | – | -40,000 | -100.0% | -0.65% | – |
| ILMN | Exit | ILLUMINA INC | $0 | – | -24,262 | -100.0% | -0.70% | – |
| Exit | ENOVIS CORPORATION | $0 | – | -95,000 | -100.0% | -0.73% | – | |
| STAA | Exit | STAAR SURGICAL CO | $0 | – | -110,200 | -100.0% | -0.77% | – |
| OFIX | Exit | ORTHOFIX MED INC | $0 | – | -295,300 | -100.0% | -0.87% | – |
| AVTE | Exit | AEROVATE THERAPEUTICS INC | $0 | – | -217,119 | -100.0% | -0.91% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -310,000 | -100.0% | -0.99% | – |
| HCA | Exit | HCA HEALTHCARE INC | $0 | – | -34,550 | -100.0% | -1.19% | – |
| LLY | Exit | LILLY ELI & CO | $0 | – | -39,100 | -100.0% | -2.05% | – |
| CVRX | Exit | CVRX INC | $0 | – | -1,014,640 | -100.0% | -2.67% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ESSA PHARMA INC | 16 | Q3 2023 | 10.8% |
| IRADIMED CORP | 16 | Q3 2023 | 5.8% |
| XENON PHARMACEUTICALS INC | 15 | Q3 2023 | 2.9% |
| IVERIC BIO INC | 14 | Q1 2023 | 6.5% |
| SURMODICS INC | 14 | Q3 2023 | 4.7% |
| NATERA INC | 13 | Q3 2023 | 3.9% |
| DEXCOM INC | 13 | Q2 2023 | 4.2% |
| NOVOCURE LTD | 13 | Q3 2023 | 3.4% |
| CRISPR THERAPEUTICS AG | 13 | Q2 2023 | 2.6% |
| LYRA THERAPEUTICS INC | 13 | Q3 2023 | 1.0% |
View Soleus Capital Management, L.P.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Soleus Capital Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.